Hi Beth, it’s Kat here, We never met but your name is talked about so often. Whether it be an amazing thing you did, a funny story, your intellect on
Emma Saville
We met Emma as she applied to be one of the METUPUK Darker Side of Pink ladies with our campaign that started in 2021 which focused on metastatic breast cancer,
“I’m definitely living. I’m not dying yet.”

Sandy Sexton, patient advocate for METUPUK, is campaigning in Scotland on behalf of secondary/metastatic Breast Cancer patients. In October last year, after 18 months of debilitating back pain, Sandy was
The Irony of Metastatic Breast Cancer

I didn’t really know what mental health was about until I was diagnosed with breast cancer. I’ve been living with the disease for almost 16 years, nearly 9 of those
METUPUK are delighted by the Scottish Medicines Consortium (SMC) acceptance of Enhertu (trastuzumab deruxtecan) for routine use on the NHS.

METUPUK are delighted by the Scottish Medicines Consortium (SMC) acceptance of Enhertu (trastuzumab deruxtecan) for routine use on the NHS. The Scottish Medicines Consortium (SMC) has accepted: Trastuzumab deruxtecan (Enhertu)
Why is Awareness of SBC important? By Fiona Macrae of @InsuranceWith

I received an email from Fiona who is the creator of InsuranceWith and it again highlights why it is so important to be aware of secondary breast cancer. She has
Postcode Lotteries

What’s your postcode and what does that say about you? If I asked a healthy person about the importance of their postcode I suspect they’d tell me about local schools,
Moo to you too!

Hi my name is Kit and apparently I’m a stubborn cow! Now the person who told me that didn’t think it was a good thing. But for a secondary breast
What’s so bad about fears and tears?

I’m 36 years old and I’m dying of secondary breast cancer. As a result I’m petrified 24/7. I’m currently waiting for scan results that will tell me if my current
Herceptin report re access to 3rd and subsequent line of therapy problem with drug access

10th July 2020 Hi Debbie, Trying to condense the points from the June email with attachments I sent you. Going forward what we would like now is – for you